BioFocus Renews French Research Tax Credit Accreditation
News Jun 09, 2010
BioFocus has announced that it had been notified by the French Ministry of Higher Education and Research, that its CIR accreditation had been renewed.
The accreditation allows eligible French companies to benefit from significant tax relief (Crédit d'Impôt sur la Recherche) on research carried out by BioFocus on their behalf until 2013. The accreditation is an extension of the current agreement, in place since 2008, covering work at both UK and The Netherlands research facilities.
“The renewal of our CIR accreditation allows our eligible clients the opportunity to receive 30% of their R&D costs in tax credits” said Richard Gordon, Senior Director, Sales and Marketing. “Clients who have benefited from this facility over the last three years can continue to do so and access BioFocus’ evolving discovery platform”.
Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT BiotechNews
Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.READ MORE
XenoGesis and BioAscent Forge Alliance to Offer Enhanced Integrated Drug Discovery ServicesNews
XenoGesis and BioAscent Discovery Limited have announced a collaboration to offer an enhanced range of integrated drug discovery services, including medicinal chemistry, biology and DMPK.READ MORE